trending Market Intelligence /marketintelligence/en/news-insights/trending/p7yw5oupyucrcymurmexxq2 content esgSubNav
In This List

Novan names board member

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy

Blog

Commercial Banking Newsletter June Edition - 2022


Novan names board member

Morrisville, N.C.-based biotechnology company Novan Inc. appointed Eugene Sun to the board, effective Feb. 16.

Sun was CEO of Melinta Therapeutics from 2015 to 2017. He also served on the now-defunct U.S. Food and Drug Administration's Antiviral Drugs Advisory Committee, a panel of infectious disease experts, from 2001 to 2007.